Şunu aradınız:: pluripotent (İngilizce - Maltaca)

one clinical trial is beginning in japan using induced pluripotent stem cells13.
il-Ġappun inbdiet prova klinika li tuża ċ-ċelloli staminali pluripotenti indotti13.

induced pluripotent stem cells (ipsc), are adult, specialised cells that have been genetically reprogrammed.
iċ-ċelloli staminali pluripotenti indotti (ipsc) huma ċelloli speċjalizzati adulti li ġew riprogrammati ġenetikament.

eu research also allows for projects that may include a comparison of different cell types, including human embryonic stem cells and induced pluripotent stem cells, keeping all avenues of research open in the light of scientific advances.
ir-riċerka tal-ue tippermetti li l-proġetti jkunu jqabblu tipi differenti ta' ċelloli, fosthom iċ-ċelloli staminali tal-embrijuni umani u ċ-ċelloli staminali pluripotenti indotti, filwaqt li kull fergħa tar-riċerka tibqa' miftuħa fid-dawl tal-avvanzi xjentifiċi.

induced pluripotent stem cells have many similar properties to embryonic stem cells and research continues to make progress; however, these cells cannot yet be produced to clinical standard or be treated as natural cells.
iċ-ċelloli staminali pluripotenti indotti u ċ-ċelloli staminali tal-embrijuni għandhom bosta proprjetajiet simili bejniethom u r-riċerka tissokta tavvanza; madankollu, dawn iċ-ċelloli ma jistgħux jiġu prodotti sal-istandard kliniku jew ma jistgħux jiġu trattati bħala ċelloli naturali.

plerixafor-induced leukocytosis and elevations in circulating haematopoietic progenitor cell levels are thought to result from a disruption of cxcr4 binding to its cognate ligand, resulting in the appearance of both mature and pluripotent cells in the systemic circulation.
hu maħsub li l-lewkoċitosi kkaġunata minn plerixafor u ż-żidiet fil- livelli taċ-ċelluli proġenituri ematopojetiċi fiċ-ċirkolazzjoni, jirriżultaw minn interruzzjoni tat-twaħħil ta’ cxcr4 mal-ligand relatat tiegħu li jirriżulta fid-dehra kemm ta’ ċelluli maturi kif ukoll pluripotenti fiċ-ċirkolazzjoni sistemika.

under the fp7 health programme (2007-2013), the eu funded 27 collaborative research projects involving the use of human embryonic stem cells; the more recent of these also include work on induced pluripotent stem cells.
bil-programm tas-saħħa tal-fp7 (2007-2013), l-ue ffinanzjat 27 proġett tar-riċerka kollaborattiva li jinvolvu l-użu ta' ċelloli staminali tal-embrijuni umani; l-aktar riċenti fosthom jinkludu wkoll riċerka fuq ċelloli staminali pluripotenti indotti.